TOXICOLOGICAL EVALUATION OF INDOMETHACIN AS A RISK FACTOR FOR WORKERS’ HEALTH
Introduction. The toxicity of indomethacin was studied for its hygienic regulation. Material and methods. The toxic properties of indomethacin in the experiments on out-bred and linear mice, rats, Guinea pigs and rabbits contained in standard vivarium conditions and quarantined have been studied. In the experiments, various modes (single, repeated, chronic) and ways of exposure (intragastric, inhalation, epicutaneous) were modeled. The average lethal dose (LD50) of Indomethacin and the threshold of a single acute action (Limac) were determined; irritant effect on the skin and mucous membranes, cumulative and allergenic activity were revealed. In subacute and chronic intake to the body, the main target organs were determined on the based of the results of biochemical and hematological studies. Results. DL50 for male rats, females and male mice, when introduced into the stomach, were have been established to be 20, 15 and 25.6 mg/kg respectively. It refers to the substances of hazard class 2. DL50 in the intraperitoneal introduction for the rats accounted for 13.8 mg/kg, for Guinea pigs - 500 mg/kg. The clinical picture of acute poisoning in mice and rats was characterized by low mobility, decreasing breathing, ataxia, muscle relaxation, anorexia, diarrhea, ulceration with the perforation of the intestines, and the death on the 2-4th days after the poisoning. In the experiments on Guinea pigs, the ulcerogenic effect was not detected. Local irritant effect on the skin and mucous membranes of the eyes was not revealed. It has a marked skin-resorptive action causing ulcerogenic effect and the death of the animals after 6 applications. The introduction of verospiron to the rats in a dose of 25 mg/kg simultaneously with the application of indomethacin ointment on the skin prevented the ulcer development in the gastrointestinal tract and the death of the animals. No sensitizing effect was detected. It has an average cumulative ability: the cumulation coefficient amounted to 2.6. In a subacute experiment, there was a decrease in the body temperature and summation-threshold index, an increase in the vertical motor activity and a threshold of pain sensitivity. During the study of blood serum an increase in AcAt activity, a rise of chlorides in the blood serum and their decrease in the urine, and an increase in the number of erythrocytes and hemoglobin in peripheral blood were revealed. In the pathomorphological study, there was an increase in the coefficients of liver mass and ulceration of the stomach and intestines. The threshold of acute inhalation action accounted for 0.52 mg/m3 (by the reduction of the summation-threshold index and the content of sodium and chlorides in the urine). Conclusion. The maximum permissible concentration of indomethacin in the air of the working area was of 0.05 mg/m3 with the mark “special protection of the skin and eyes”, hazard class 1, aerosol.
About the authorsMartynova N.A.
Gorokhova Larisa G.
The main indicators of public health and health care of the Siberian Federal District in 2017. Collection of statistical and analytical materials. Ed. O.V. Strel’chenko. Novosibirsk: Sibirskoe universitetskoe izdatel’stvo; 2018. 277 c. (in Russian)
Izmerov N.F., Bukhtiyarov I.V., Prokopenko L.V., Shigan E.E. Russian Federation implementation of WHO global efforts plan on workers health care. Meditsina truda i promyshlennaya ekologiya. 2015; (9): 4-10. (in Russian).
Gorokhova L.G., Martynova N.A., Kizichenko N.V., Logunova T.D. Hygienic aspects of the health status of workers in the chemical and pharmaceutical production. Meditsina v Kuzbasse. 2017; (3): 11-16. (in Russian)
Rakhmanin Yu.A. Actual problems of human ecology and environmental hygiene and solutions. Gigiena i sanitariya [Hygiene and Sanitation, Russian journal]. 2012; (5): 4-8. (in Russian)
Rakhmanin Yu.A. Actualization of methodological problems of reglamentation of chemical pollutions on the environment. Gigiena i sanitariya [Hygiene and Sanitation, Russian journal]. 2016; 95 (8): 701-7. (in Russian).
Kurlyandsky B.A., ed. General toxicology. Moscow: Meditsina; 2002. 606 p. (in Russian).
Martynova N.A., Gorokhova L.G. Toxicological characteristics of the cinnamic. Gigiena i sanitariya [Hygiene and Sanitation, Russian journal]. 2016; 95 (8): 779-81 (in Russian).
Gorokhova L.G., Ulanova E.V., Shavtsova G.M., Erdeeva S.V., Blazhina O.N. The health status of workers in the chemical and pharmaceutical industry. Meditsina truda i promyshlennaya ekologiya. 2018; 6: 38-42. (in Russian)
Lee Y.C. Effect and treatment of chronic pain in inflammatory arthritis. Curr. Rheumatol. Rep. 2013; 15 (1): 30
Bel’skaya G.N., Sergienko D.A., Makarova L.D., Stepanova S.B., Luzanova E.I., Krylova L.G. Rational use of nonsteroidal anti-inflammatory drugs for pain syndromes in clinical practice. Russkiy meditsinskiy zhurnal. 2015; 23 (16): 957-960. (in Russian)
Zhuravleva M.V., Kukes V.G., Prokof’ev A.B., Serebrova S.Yu., Gorodetskaya G.I., Berdnikova N.G. Rational use of NSAIDs - the balance of efficacy and safety (literature review). Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy. 2016; 6-4: 687-696. (in Russian)
Vasilevskiy I.V. Clinical and pharmacological heterogeneity of nonsteroidal anti-inflammatory drugs. Voprosy organizatsii i informatizatsii zdravookhraneniya. 2015; S: 16-23. (in Russian)
Mashkovsky M.D. Medicines. Part 1. Moscow: Meditsina; 1993. 736 p. (in Russian).
Karateyev A.E. Criteria of NSAID safety. Klinicheskaya farmakologiya i terapiya. 2011; 20 (1): 74-80 (in Russian).
Selye H. Role of the liver in the prevention of indomethacin-induced intestinal ulcers by spironolactone. Acta Hepato-splenologica. 1970; 17 (6): 393-7.
Arnold L., Collins C., Starmer G.A. Renal and gastric lesions after phenylbutazone and indomethacin in the rat. Pathology. 1974; 6 (4): 303-13.
Gaetani M., Debeus R., Vidi A., Coppi G. A comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indomethacin and benzydamine) in the rat. Arzneimittel-Forschung. 1972; 22 (1) Suppl 1a: 226-33.
Coricciati L., Maconi F. Our clinical experience with indomethacin in some cutaneous diseases. Minerva dermatologica. 1967; 42 (8): 411-2.
Winer J. Indomethacin. Schweizerische medizinische Wochenschrift. 1966; 96 (52): 1759-60.
Martynova N.A., Gorokhova L.G. Evaluation of the toxicity of sulpiride as the basis of its hygienic rationing. Gigiena i sanitariya [Hygiene and Sanitation, Russian journal]. 2015; 94 (1): 114-11. (in Russian).
Medik V.A., Tokmachev M.S., Fishman B.B. Statistics in medicine and biology. M.: Meditsina; 2000. 412s. (in Russian).
Efimov A.L., Sigua B.V., Filaretova L.P. Acute ulcers and erosions of the gastrointestinal tract induced by non-steroidal anti-inflammatory drugs: etiology, pathogenesis, treatment tactics. Vestnik Rossiyskoy voenno-meditsinskoy akademii. 2017; 1 (57): 198-20. (in Russian).
Gladkikh F.V. Preventive and therapeutic strategies for pharmacocorrection of gastropathy induced by non-steroidal anti-inflammatory drugs. Obzory po klinicheskoy farmakologii i lekarstvennoy terapii. 2017; 15 (4): 14-23. (in Russian).
Chichasova N.V. Local NSAIDs in the treatment of joint and spine disease. Klinicheskaya farmakologiya i terapiya. 2014; 23 (4): 79-84. (in Russian).
Um S.Y., Park J.H., Chung M.W., Kim S.H., Choi K.H., Lee H.J. Nuclear magnetic resonance-based metabolomics for prediction of gastric damage induced by indomethacin in rats. Analytica chimica acta. 2012; Apr. 13 (722): 87-94.
Navakatikyan M.A., Platonov L.A. Labyrinth for the study of motor activity of white rats. Gigiena i sanitariya [Hygiene and Sanitation, Russian journal]. 1988; (2): 60-2 (in Russian).
Osadchuk M.M., Uryupin A.A., Golyshkov S.B. NSAID-gastropathy: risk factors and ways of prevention. Eksperimental’naya i klinicheskaya gastroenterologiya. 2014; 5 (105): 75a. (in Russian).
Tsimmerman Ya.S. Gastric damage caused by nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs-gastritis or NSAIDs-gastropathy? Klinicheskaya farmakologiya i terapiya. 2018; 27 (1): 14-21. (in Russian).
Martynova N.A. To the issue of prevention of NSAID-associated gastroenteropathy. Meditsina v Kuzbasse. 2016; 15 (4): 21-3. (in Russian).
Gushchin Ya.A., Muzhikyan A.A., Shed’ko V.V., Makarova M.N., Makarov V.G. Comparative anatomy of the upper gastrointestinal tract of experimental animals and humans. Mezhdunarodnyy vestnik veterinarii. 2017; 3: 116-129. (in Russian).
- Refbacks are not listed
Контент доступен под лицензией Creative Commons Attribution 3.0 License.